慢性病:使用可生物降解或其合金作为潜在的骨科植入物的禁忌?
Lizhen Zheng1,2, Ri Zhang2, Xin Chen2
1Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences, Hong Kong Special Administrative Region of China, People's Republic of China.
Biomedical materials (Bristol, England)
|May 30, 2024
概括
可生物降解的 (Mg) 骨科植入物对慢性病 (CKD) 患者是安全的. 长期研究表明,CKD大鼠的Mg水平没有增加或器官损伤,这表明它适合于更广泛的患者使用.
科学领域:
- 生物材料科学 生物材料科学
- 整形外科手术 整形外科手术
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- (Mg) 是一个有前途的骨科生物材料.
- 基于Mg的植入物在患有慢性病 (CKD) 的患者的安全性是未知的,因为脏在矿物质平衡中的作用.
研究的目的:
- 评估可生物降解的Mg和Mg-Sr-Zn合金骨科植入物的长期生物安全性,在CKD的老鼠模型中.
主要方法:
- 通过5/6次全切除术创建了一种大鼠CKD模型.
- 不钢,高纯度Mg和Mg-Sr-Zn合金引脚的内植入.
- 在12周内对生物安全的系统评估,包括血清Mg水平,器官组织学和细胞分析.
主要成果:
- 血清Mg水平或主要器官 (心脏,肝脏,脏,肺部,脏) 的Mg积累没有显著增加.
- 通过组织学检查,没有观察到器官的病理变化.
- 在测试的器官中,iNOS阳性或亡细胞的数量没有增加.
结论:
- 可生物降解的Mg和Mg-Sr-Zn合金骨科植入物对CKD老鼠没有额外的健康风险.
- 这些基于Mg的骨科设备可能适合CKD患者.
相关概念视频
Bone Disorders
8.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
8.0K
Drug Distribution: Tissue Binding
3.7K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
3.7K
Chronic Bowel Disorders: Introduction
900
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
900
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
755
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
755


